US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.14

-0.0900-4.04%

Post-market: 2.12-0.0200-0.93%18:10 EDT

Volume:1.54M

Turnover:3.31M

Market Cap:172.10M

PE:-26.11

High:2.24

Open:2.21

Low:2.11

Close:2.23

52wk High:3.19

52wk Low:1.32

Shares:80.42M

Float Shares:60.76M

Volume Ratio:1.09

T/O Rate:2.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0820

EPS(LYR):-0.0841

ROE:-14.44%

ROA:-4.41%

PB:3.57

PE(LYR):-25.45

Loading ...

Overview Company News Filings

Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing

Bernstein Remains a Hold on PLUXEE N.V. (PLX)

Kepler Capital Remains a Buy on PLUXEE N.V. (PLX)

Protalix BioTherapeutics showcases pipeline advances and growth strategy for rare disease treatments

Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)

Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges

Protalix BioTherapeutics Q3 EPS USD 0.03

Protalix BioTherapeutics Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.673M Miss $17.866M Estimate

Press Release: Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Protalix BioTherapeutics Inc. to Report Third Quarter 2025 Financial Results

Bernstein Reaffirms Their Hold Rating on PLUXEE N.V. (PLX)

Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing

Protalix BioTherapeutics and Chiesi Seek EMA Re-examination for Elfabrio Alternative Dosing in EU

J.P. Morgan Sticks to Its Hold Rating for PLUXEE N.V. (PLX)

PLUXEE N.V. (PLX) Gets a Buy from Kepler Capital

PLUXEE N.V. (PLX) Gets a Hold from UBS

How Could EMA's Elfabrio Decision Reshape Protalix BioTherapeutics' (PLX) Rare Disease Strategy?

Simply Wall St.

Why Is Protalix BioTherapeutics Stock Falling On Friday?

Benzinga_recent_news

Protalix Shares Sink After EMA Rejects Once-Monthly Treatment Plan

Protalix BioTherapeutics Highlights Rare Disease Drug Pipeline and New Gout Therapy in Latest Corporate Presentation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PLX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics","latestPrice":2.14,"timestamp":1774036800000,"preClose":2.23,"halted":0,"volume":1539537,"hourTrading":{"tag":"盘后","latestPrice":2.12,"preClose":2.14,"latestTime":"18:10 EDT","volume":44377,"amount":94951.645,"timestamp":1774044641834,"change":-0.02,"changeRate":-0.009346,"amplitude":0.018692},"delay":0,"changeRate":-0.04035874439461877,"floatShares":60755281,"shares":80421181,"eps":-0.08196432,"marketStatus":"Market Closed","change":-0.09,"latestTime":"03-20 16:00:00 EDT","open":2.21,"high":2.24,"low":2.11,"amount":3314202.4055379,"amplitude":0.058296,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.08196432,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":2.23,"preHourTrading":{"tag":"盘前","latestPrice":2.1991,"preClose":2.23,"latestTime":"09:11 EDT","volume":26721,"amount":57455.89501500001,"timestamp":1774012296005,"change":-0.0309,"changeRate":-0.013857,"amplitude":0.035336},"postHourTrading":{"tag":"盘后","latestPrice":2.12,"preClose":2.14,"latestTime":"18:10 EDT","volume":44377,"amount":94951.645,"timestamp":1774044641834,"change":-0.02,"changeRate":-0.009346,"amplitude":0.018692},"volumeRatio":1.0880673934702572,"impliedVol":0.4188,"impliedVolPercentile":0.2072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","floatShares":60755281,"roa":"-4.41%","roe":"-14.44%","lyrEps":-0.084077,"volumeRatio":1.0880673934702572,"shares":80421181,"dividePrice":0,"high":2.24,"amplitude":0.058296,"preClose":2.23,"low":2.11,"week52Low":1.32,"pbRate":"3.57","psRate":"3.26","week52High":3.19,"institutionHeld":0.3271,"latestPrice":2.14,"eps":-0.08196432,"divideRate":0,"volume":1539537,"delay":0,"ttmEps":-0.08196432,"open":2.21,"prevYearClose":1.8,"prevWeekClose":2.83,"prevMonthClose":2.88,"prevQuarterClose":1.8,"fiveDayClose":2.83,"twentyDayClose":3.06,"sixtyDayClose":1.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-18","symbol":"PLX","fiscalQuarterEnding":"2025/12","expectedEps":0.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-11-13","symbol":"PLX","fiscalQuarterEnding":"2025/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2025-08-14","symbol":"PLX","fiscalQuarterEnding":"2025/06","expectedEps":0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-05-09","symbol":"PLX","fiscalQuarterEnding":"2025/03","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-17","symbol":"PLX","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLX","date":"2026-03-20","current":-26.108922,"percent":0.021969,"low":-43.274752,"twenty":-6.909674,"median":-2.122315,"eighty":19.694785,"high":81.705333,"avg":5.35797,"sd":19.595791,"marketCap":179674761},"quantilePoints":[{"date":"2021-03-26","current":-33.066688,"twenty":-5.93244,"median":-2.159816,"eighty":-1.286168,"marketCap":219199073},{"date":"2021-04-01","current":-31.238527,"twenty":-6.011792,"median":-2.159816,"eighty":-1.286168,"marketCap":203768911},{"date":"2021-04-09","current":-36.595691,"twenty":-6.161232,"median":-2.158792,"eighty":-1.286095,"marketCap":238713691},{"date":"2021-04-16","current":-43.135605,"twenty":-6.301781,"median":-2.158792,"eighty":-1.286095,"marketCap":281373552},{"date":"2021-04-23","current":-43.274752,"twenty":-6.484124,"median":-2.158792,"eighty":-1.286095,"marketCap":282281208},{"date":"2021-04-30","current":-23.307141,"twenty":-6.640471,"median":-2.159816,"eighty":-1.286168,"marketCap":152032483},{"date":"2021-05-07","current":-21.150361,"twenty":-6.746429,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-05-14","current":-9.099814,"twenty":-6.956439,"median":-2.159816,"eighty":-1.286168,"marketCap":124348956},{"date":"2021-05-21","current":-9.664401,"twenty":-7.610873,"median":-2.159816,"eighty":-1.286168,"marketCap":132064038},{"date":"2021-05-28","current":-10.096144,"twenty":-9.073245,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-06-04","current":-7.107154,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":97119258},{"date":"2021-06-11","current":-7.206787,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":98480743},{"date":"2021-06-18","current":-6.6422,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":90765662},{"date":"2021-06-25","current":-6.608989,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":90311833},{"date":"2021-07-02","current":-5.97798,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":81689095},{"date":"2021-07-09","current":-5.745503,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":78512297},{"date":"2021-07-16","current":-5.247338,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71704872},{"date":"2021-07-23","current":-5.214127,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71251044},{"date":"2021-07-30","current":-5.014861,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68528074},{"date":"2021-08-06","current":-4.98165,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68074246},{"date":"2021-08-13","current":-4.450274,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":60812993},{"date":"2021-08-20","current":-2.941121,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":61045906},{"date":"2021-08-27","current":-3.511786,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":72890635},{"date":"2021-09-03","current":-3.533735,"twenty":-9.093172,"median":-2.165862,"eighty":-1.286241,"marketCap":73346201},{"date":"2021-09-10","current":-3.2923,"twenty":-9.093172,"median":-2.168414,"eighty":-1.286241,"marketCap":68334970},{"date":"2021-09-17","current":-3.072813,"twenty":-9.093172,"median":-2.169861,"eighty":-1.286241,"marketCap":63779305},{"date":"2021-09-24","current":-2.875275,"twenty":-9.093172,"median":-2.173457,"eighty":-1.286241,"marketCap":59679207},{"date":"2021-10-01","current":-2.743583,"twenty":-9.093172,"median":-2.185224,"eighty":-1.286241,"marketCap":56945808},{"date":"2021-10-08","current":-2.919172,"twenty":-9.08653,"median":-2.194729,"eighty":-1.286241,"marketCap":60590340},{"date":"2021-10-15","current":-2.699686,"twenty":-9.08653,"median":-2.198569,"eighty":-1.286241,"marketCap":56034675},{"date":"2021-10-22","current":-2.546045,"twenty":-9.08653,"median":-2.208245,"eighty":-1.286241,"marketCap":52845710},{"date":"2021-10-29","current":-2.480199,"twenty":-9.08653,"median":-2.213276,"eighty":-1.286241,"marketCap":51479011},{"date":"2021-11-05","current":-2.436302,"twenty":-9.08653,"median":-2.224699,"eighty":-1.286241,"marketCap":50567878},{"date":"2021-11-12","current":-2.502148,"twenty":-9.08653,"median":-2.237881,"eighty":-1.286241,"marketCap":51934577},{"date":"2021-11-19","current":-2.175919,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":44645514},{"date":"2021-11-26","current":-2.198123,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":45101080},{"date":"2021-12-03","current":-1.806013,"twenty":-9.08653,"median":-2.233869,"eighty":-1.286241,"marketCap":37055776},{"date":"2021-12-10","current":-2.038925,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":41834668},{"date":"2021-12-17","current":-1.940121,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":39807398},{"date":"2021-12-23","current":-2.10931,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":43278814},{"date":"2021-12-31","current":-1.846645,"twenty":-9.079887,"median":-2.228368,"eighty":-1.286241,"marketCap":37889463},{"date":"2022-01-07","current":-1.90948,"twenty":-9.073245,"median":-2.222793,"eighty":-1.286241,"marketCap":39178716},{"date":"2022-01-14","current":-1.909036,"twenty":-9.073245,"median":-2.219151,"eighty":-1.286241,"marketCap":39169605},{"date":"2022-01-21","current":-1.809011,"twenty":-9.073245,"median":-2.213239,"eighty":-1.286241,"marketCap":37117278},{"date":"2022-01-28","current":-1.800151,"twenty":-9.073245,"median":-2.199659,"eighty":-1.286241,"marketCap":36935507},{"date":"2022-02-04","current":-2.286936,"twenty":-9.073245,"median":-2.19473,"eighty":-1.286241,"marketCap":46923346},{"date":"2022-02-11","current":-2.053801,"twenty":-9.073245,"median":-2.192317,"eighty":-1.286241,"marketCap":42139898},{"date":"2022-02-18","current":-1.900155,"twenty":-9.073245,"median":-2.182859,"eighty":-1.286241,"marketCap":38987378},{"date":"2022-02-25","current":-1.845979,"twenty":-9.073245,"median":-2.171729,"eighty":-1.286241,"marketCap":37875796},{"date":"2022-03-04","current":-1.953887,"twenty":-9.073245,"median":-2.164775,"eighty":-1.286241,"marketCap":40089849},{"date":"2022-03-11","current":-1.931683,"twenty":-9.073245,"median":-2.149114,"eighty":-1.286241,"marketCap":39634282},{"date":"2022-03-18","current":-2.331342,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":47834479},{"date":"2022-03-25","current":-2.58668,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":53073493},{"date":"2022-04-01","current":-1.763177,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":48631935},{"date":"2022-04-08","current":-2.518824,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":69474193},{"date":"2022-04-14","current":-2.199773,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":60674128},{"date":"2022-04-22","current":-2.000411,"twenty":-9.073245,"median":-2.122964,"eighty":-1.286241,"marketCap":55175340},{"date":"2022-04-29","current":-1.950023,"twenty":-9.073245,"median":-2.109577,"eighty":-1.286241,"marketCap":53785525},{"date":"2022-05-06","current":-1.907996,"twenty":-9.073245,"median":-2.106167,"eighty":-1.286241,"marketCap":52626354},{"date":"2022-05-13","current":-1.781917,"twenty":-9.073245,"median":-2.101634,"eighty":-1.296523,"marketCap":49148841},{"date":"2022-05-20","current":-2.19949,"twenty":-9.073245,"median":-2.104124,"eighty":-1.305734,"marketCap":53652162},{"date":"2022-05-27","current":-2.19949,"twenty":-9.073245,"median":-2.108744,"eighty":-1.316067,"marketCap":53652162},{"date":"2022-06-03","current":-2.392428,"twenty":-9.073245,"median":-2.111908,"eighty":-1.325755,"marketCap":58358492},{"date":"2022-06-10","current":-2.160903,"twenty":-9.073245,"median":-2.122315,"eighty":-1.336668,"marketCap":52710896},{"date":"2022-06-17","current":-2.103021,"twenty":-9.073245,"median":-2.122315,"eighty":-1.340638,"marketCap":51298997},{"date":"2022-06-24","current":-2.103021,"twenty":-9.079887,"median":-2.122315,"eighty":-1.345105,"marketCap":51298997},{"date":"2022-07-01","current":-2.093374,"twenty":-9.079887,"median":-2.123693,"eighty":-1.358968,"marketCap":51063680},{"date":"2022-07-08","current":-2.141609,"twenty":-9.079887,"median":-2.128772,"eighty":-1.362564,"marketCap":52240263},{"date":"2022-07-15","current":-2.083727,"twenty":-9.079887,"median":-2.129233,"eighty":-1.365604,"marketCap":50828364},{"date":"2022-07-22","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.382433,"marketCap":49887098},{"date":"2022-07-29","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.400792,"marketCap":49887098},{"date":"2022-08-05","current":-2.122315,"twenty":-9.079887,"median":-2.129233,"eighty":-1.416087,"marketCap":51769630},{"date":"2022-08-12","current":-2.363487,"twenty":-9.079887,"median":-2.141609,"eighty":-1.428705,"marketCap":57652542},{"date":"2022-08-19","current":-3.229692,"twenty":-9.079887,"median":-2.151454,"eighty":-1.454072,"marketCap":59704090},{"date":"2022-08-26","current":-3.175864,"twenty":-9.079887,"median":-2.160903,"eighty":-1.46638,"marketCap":58709022},{"date":"2022-09-02","current":-2.933637,"twenty":-9.079887,"median":-2.168513,"eighty":-1.513357,"marketCap":54231215},{"date":"2022-09-09","current":-2.866352,"twenty":-9.079887,"median":-2.173457,"eighty":-1.552879,"marketCap":52987380},{"date":"2022-09-16","current":-3.068208,"twenty":-9.079887,"median":-2.185224,"eighty":-1.597561,"marketCap":56718886},{"date":"2022-09-23","current":-2.772152,"twenty":-9.079887,"median":-2.19473,"eighty":-1.642895,"marketCap":51246011},{"date":"2022-09-30","current":-2.802835,"twenty":-9.079887,"median":-2.19949,"eighty":-1.691667,"marketCap":51813200},{"date":"2022-10-07","current":-2.799067,"twenty":-9.079887,"median":-2.205652,"eighty":-1.708303,"marketCap":51743545},{"date":"2022-10-14","current":-2.745238,"twenty":-9.079887,"median":-2.213275,"eighty":-1.720523,"marketCap":50748477},{"date":"2022-10-21","current":-2.772152,"twenty":-9.079887,"median":-2.225261,"eighty":-1.725838,"marketCap":51246011},{"date":"2022-10-28","current":-2.772152,"twenty":-9.079887,"median":-2.240109,"eighty":-1.732273,"marketCap":51246011},{"date":"2022-11-04","current":-2.718324,"twenty":-9.079887,"median":-2.242805,"eighty":-1.755663,"marketCap":50250943},{"date":"2022-11-11","current":-2.825981,"twenty":-9.079887,"median":-2.250369,"eighty":-1.765675,"marketCap":52241079},{"date":"2022-11-18","current":-3.036417,"twenty":-9.079887,"median":-2.262195,"eighty":-1.778799,"marketCap":54212189},{"date":"2022-11-25","current":-3.391139,"twenty":-9.079887,"median":-2.26358,"eighty":-1.789218,"marketCap":60545389},{"date":"2022-12-02","current":-3.206683,"twenty":-9.079887,"median":-2.278354,"eighty":-1.795365,"marketCap":57252125},{"date":"2022-12-09","current":-3.320194,"twenty":-9.079887,"median":-2.292748,"eighty":-1.799662,"marketCap":59278749},{"date":"2022-12-16","current":-3.291817,"twenty":-9.079887,"median":-2.300018,"eighty":-1.807377,"marketCap":58772093},{"date":"2022-12-23","current":-3.348572,"twenty":-9.079887,"median":-2.308362,"eighty":-1.815181,"marketCap":59785405},{"date":"2022-12-30","current":-3.887749,"twenty":-9.079887,"median":-2.330304,"eighty":-1.816065,"marketCap":69411869},{"date":"2023-01-06","current":-4.341793,"twenty":-9.079887,"median":-2.331425,"eighty":-1.819992,"marketCap":77518364},{"date":"2023-01-13","current":-4.597192,"twenty":-9.079887,"median":-2.347715,"eighty":-1.827125,"marketCap":82078268},{"date":"2023-01-20","current":-4.739081,"twenty":-9.079887,"median":-2.35453,"eighty":-1.836965,"marketCap":84611548},{"date":"2023-01-27","current":-4.455303,"twenty":-9.079887,"median":-2.366765,"eighty":-1.846672,"marketCap":79544988},{"date":"2023-02-03","current":-4.597192,"twenty":-9.079887,"median":-2.372929,"eighty":-1.855292,"marketCap":82078268},{"date":"2023-02-10","current":-4.483681,"twenty":-9.079887,"median":-2.377975,"eighty":-1.863262,"marketCap":80051644},{"date":"2023-02-17","current":-4.426926,"twenty":-9.079887,"median":-2.386937,"eighty":-1.865474,"marketCap":79038332},{"date":"2023-02-24","current":-5.164747,"twenty":-9.079887,"median":-2.395361,"eighty":-1.8693,"marketCap":92211388},{"date":"2023-03-03","current":-7.880419,"twenty":-9.079887,"median":-2.409349,"eighty":-1.87939,"marketCap":117631009},{"date":"2023-03-10","current":-7.111597,"twenty":-9.079887,"median":-2.414353,"eighty":-1.887277,"marketCap":106154813},{"date":"2023-03-17","current":-7.803536,"twenty":-9.079887,"median":-2.420155,"eighty":-1.897474,"marketCap":116483389},{"date":"2023-03-24","current":-7.649772,"twenty":-9.079887,"median":-2.433443,"eighty":-1.901141,"marketCap":114188150},{"date":"2023-03-31","current":-8.072624,"twenty":-9.073245,"median":-2.439918,"eighty":-1.90865,"marketCap":120500058},{"date":"2023-04-06","current":-8.226388,"twenty":-9.073245,"median":-2.446146,"eighty":-1.912148,"marketCap":122795297},{"date":"2023-04-14","current":-9.571826,"twenty":-9.400542,"median":-2.46771,"eighty":-1.922938,"marketCap":142878640},{"date":"2023-04-21","current":-8.956768,"twenty":-9.457132,"median":-2.480199,"eighty":-1.931683,"marketCap":133697683},{"date":"2023-04-28","current":-10.263765,"twenty":-9.567591,"median":-2.502031,"eighty":-1.934828,"marketCap":153207216},{"date":"2023-05-05","current":-14.724601,"twenty":-9.651117,"median":-2.520118,"eighty":-1.939455,"marketCap":219794121},{"date":"2023-05-12","current":-10.576213,"twenty":-10.196717,"median":-2.536056,"eighty":-1.94368,"marketCap":166808038},{"date":"2023-05-19","current":-9.162809,"twenty":-10.196717,"median":-2.545576,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-05-26","current":-8.948724,"twenty":-10.196717,"median":-2.560684,"eighty":-1.945022,"marketCap":141139282},{"date":"2023-06-02","current":-9.162809,"twenty":-10.196717,"median":-2.582062,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-06-09","current":-9.976329,"twenty":-10.332959,"median":-2.61351,"eighty":-1.945022,"marketCap":157346663},{"date":"2023-06-16","current":-9.633794,"twenty":-10.332959,"median":-2.630673,"eighty":-1.945022,"marketCap":151944203},{"date":"2023-06-23","current":-9.505344,"twenty":-10.356023,"median":-2.656774,"eighty":-1.945022,"marketCap":149918280},{"date":"2023-06-30","current":-9.291259,"twenty":-10.379088,"median":-2.691448,"eighty":-1.945022,"marketCap":146541742},{"date":"2023-07-07","current":-7.664219,"twenty":-10.379088,"median":-2.708789,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-14","current":-7.664219,"twenty":-10.379088,"median":-2.729688,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-21","current":-7.364501,"twenty":-10.379088,"median":-2.745103,"eighty":-1.945022,"marketCap":116152902},{"date":"2023-07-28","current":-7.150416,"twenty":-10.379088,"median":-2.745238,"eighty":-1.945022,"marketCap":112776364},{"date":"2023-08-04","current":-7.364501,"twenty":-10.38417,"median":-2.755336,"eighty":-1.944575,"marketCap":116152902},{"date":"2023-08-11","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-08-18","current":15.359988,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":136719255},{"date":"2023-08-25","current":16.244595,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":144593139},{"date":"2023-09-01","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-09-08","current":14.797057,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":131708602},{"date":"2023-09-15","current":13.91245,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":123834718},{"date":"2023-09-22","current":13.349518,"twenty":-10.38417,"median":-2.755336,"eighty":-1.937003,"marketCap":118824064},{"date":"2023-09-29","current":12.947425,"twenty":-10.38417,"median":-2.755336,"eighty":-1.931683,"marketCap":115245026},{"date":"2023-10-06","current":12.867006,"twenty":-10.38417,"median":-2.74793,"eighty":-1.924528,"marketCap":114529219},{"date":"2023-10-13","current":11.982399,"twenty":-10.38417,"median":-2.74793,"eighty":-1.91452,"marketCap":106655335},{"date":"2023-10-20","current":11.741143,"twenty":-10.38417,"median":-2.74793,"eighty":-1.909391,"marketCap":104507912},{"date":"2023-10-27","current":11.982399,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":106655335},{"date":"2023-11-03","current":13.590775,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":120971487},{"date":"2023-11-10","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899704,"marketCap":101403452},{"date":"2023-11-17","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":101403452},{"date":"2023-11-24","current":9.826821,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":104321537},{"date":"2023-12-01","current":10.376574,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":110157707},{"date":"2023-12-08","current":11.682235,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":124018610},{"date":"2023-12-15","current":12.09455,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":128395738},{"date":"2023-12-22","current":11.957111,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":126936695},{"date":"2023-12-29","current":12.369426,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":131313823},{"date":"2024-01-05","current":11.957111,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":126936695},{"date":"2024-01-12","current":11.269921,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":119641483},{"date":"2024-01-19","current":10.101698,"twenty":-10.438841,"median":-2.771211,"eighty":-1.899583,"marketCap":107239622},{"date":"2024-01-26","current":10.376574,"twenty":-10.404498,"median":-2.770538,"eighty":-1.898048,"marketCap":110157707},{"date":"2024-02-02","current":10.101698,"twenty":-10.404498,"median":-2.770538,"eighty":-1.887499,"marketCap":107239622},{"date":"2024-02-09","current":10.307855,"twenty":-10.404498,"median":-2.770538,"eighty":-1.878194,"marketCap":109428186},{"date":"2024-02-16","current":10.445293,"twenty":-10.404498,"median":-2.770538,"eighty":-1.865074,"marketCap":110887228},{"date":"2024-02-23","current":9.826821,"twenty":-10.404498,"median":-2.770538,"eighty":-1.859242,"marketCap":104321537},{"date":"2024-03-01","current":11.201202,"twenty":-10.399416,"median":-2.764616,"eighty":-1.84065,"marketCap":118911962},{"date":"2024-03-08","current":10.032979,"twenty":-10.399416,"median":-2.764616,"eighty":-1.815126,"marketCap":106510101},{"date":"2024-03-15","current":12.024111,"twenty":-10.399416,"median":-2.764616,"eighty":-1.798801,"marketCap":99944409},{"date":"2024-03-22","current":11.601155,"twenty":-10.399416,"median":-2.753312,"eighty":-1.765715,"marketCap":96428803},{"date":"2024-03-28","current":10.985943,"twenty":-10.399416,"median":-2.753312,"eighty":-1.731141,"marketCap":91315155},{"date":"2024-04-05","current":10.634392,"twenty":-10.404498,"median":-2.758695,"eighty":-1.704982,"marketCap":88393070},{"date":"2024-04-12","current":10.72228,"twenty":-10.404498,"median":-2.758695,"eighty":-1.630901,"marketCap":89123591},{"date":"2024-04-19","current":9.931292,"twenty":-10.404498,"median":-2.758695,"eighty":-1.553621,"marketCap":82548900},{"date":"2024-04-26","current":10.37073,"twenty":-10.399416,"median":-2.753312,"eighty":-1.502768,"marketCap":86201506},{"date":"2024-05-03","current":10.231792,"twenty":-10.399416,"median":-2.753312,"eighty":-1.45681,"marketCap":85046657},{"date":"2024-05-10","current":11.025638,"twenty":-10.399416,"median":-2.753312,"eighty":-1.426977,"marketCap":91645105},{"date":"2024-05-17","current":12.526258,"twenty":-10.399416,"median":-2.753312,"eighty":-1.393687,"marketCap":85779818},{"date":"2024-05-24","current":12.633321,"twenty":-10.399416,"median":-2.753312,"eighty":-1.35988,"marketCap":86512979},{"date":"2024-05-31","current":12.205072,"twenty":-10.399416,"median":-2.753312,"eighty":-1.337474,"marketCap":83580335},{"date":"2024-06-07","current":12.09801,"twenty":-10.399416,"median":-2.746584,"eighty":-1.32008,"marketCap":82847174},{"date":"2024-06-14","current":12.419196,"twenty":-10.404498,"median":-2.745238,"eighty":-1.307985,"marketCap":85046657},{"date":"2024-06-21","current":12.526258,"twenty":-10.438841,"median":-2.746584,"eighty":-1.281516,"marketCap":85779818},{"date":"2024-06-28","current":13.811003,"twenty":-10.54187,"median":-2.758695,"eighty":-1.257877,"marketCap":94577748},{"date":"2024-07-05","current":11.134452,"twenty":-10.54187,"median":-2.758695,"eighty":-1.2431,"marketCap":76248727},{"date":"2024-07-12","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.222499,"marketCap":83580335},{"date":"2024-07-15","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.212089,"marketCap":83580335},{"date":"2024-08-02","current":11.348576,"twenty":-11.649165,"median":-2.772152,"eighty":-1.193601,"marketCap":77715049},{"date":"2024-08-09","current":11.134452,"twenty":-11.649165,"median":-2.772152,"eighty":-1.178742,"marketCap":76248727},{"date":"2024-08-16","current":-4.754699,"twenty":-11.649165,"median":-2.772152,"eighty":-1.164919,"marketCap":69865540},{"date":"2024-08-23","current":-4.697142,"twenty":-11.649165,"median":-2.793651,"eighty":-1.164919,"marketCap":69019799},{"date":"2024-08-30","current":-4.555001,"twenty":-11.649165,"median":-2.799067,"eighty":-1.164919,"marketCap":66931187},{"date":"2024-09-06","current":-5.105045,"twenty":-11.649165,"median":-2.825981,"eighty":-1.172176,"marketCap":75013527},{"date":"2024-09-13","current":-5.305243,"twenty":-11.649165,"median":-2.832709,"eighty":-1.172176,"marketCap":77955234},{"date":"2024-09-20","current":-5.755688,"twenty":-11.649165,"median":-2.864199,"eighty":-1.172176,"marketCap":84574075},{"date":"2024-09-27","current":-5.355292,"twenty":-11.649165,"median":-2.877542,"eighty":-1.183349,"marketCap":78690661},{"date":"2024-10-04","current":-5.054995,"twenty":-11.649165,"median":-2.919172,"eighty":-1.235399,"marketCap":74278100},{"date":"2024-10-11","current":-5.004946,"twenty":-11.649165,"median":-2.926909,"eighty":-1.318237,"marketCap":73542674},{"date":"2024-10-18","current":-5.455391,"twenty":-11.649165,"median":-2.961811,"eighty":-1.343261,"marketCap":80161514},{"date":"2024-10-25","current":-5.155094,"twenty":-11.649165,"median":-3.006085,"eighty":-1.359997,"marketCap":75748954},{"date":"2024-10-31","current":-5.855787,"twenty":-11.649165,"median":-3.008039,"eighty":-1.398056,"marketCap":86044928},{"date":"2024-11-08","current":-5.805737,"twenty":-11.689082,"median":-3.036417,"eighty":-1.525183,"marketCap":85309501},{"date":"2024-11-15","current":-7.056974,"twenty":-11.689082,"median":-3.072813,"eighty":-1.58483,"marketCap":103695170},{"date":"2024-11-22","current":-12.724521,"twenty":-11.98416,"median":-3.14895,"eighty":-1.643965,"marketCap":122231747},{"date":"2024-11-29","current":-13.184443,"twenty":-12.17163,"median":-3.149928,"eighty":-1.708859,"marketCap":126649762},{"date":"2024-12-06","current":-12.49456,"twenty":-12.366043,"median":-3.229692,"eighty":-1.708859,"marketCap":120022740},{"date":"2024-12-13","current":-13.797673,"twenty":-12.463249,"median":-3.291817,"eighty":-1.71628,"marketCap":132540449},{"date":"2024-12-20","current":-13.337751,"twenty":-12.497966,"median":-3.310435,"eighty":-1.73821,"marketCap":128122434},{"date":"2024-12-27","current":-13.644366,"twenty":-12.532682,"median":-3.320194,"eighty":-1.780748,"marketCap":131067777},{"date":"2025-01-03","current":-15.100787,"twenty":-12.605949,"median":-3.348572,"eighty":-1.788536,"marketCap":145058158},{"date":"2025-01-10","current":-17.400399,"twenty":-12.708302,"median":-3.419516,"eighty":-1.785226,"marketCap":167148233},{"date":"2025-01-17","current":-16.633862,"twenty":-12.808567,"median":-3.52276,"eighty":-1.785226,"marketCap":159784875},{"date":"2025-01-24","current":-19.393396,"twenty":-12.953442,"median":-3.648888,"eighty":-1.785226,"marketCap":186292964},{"date":"2025-01-31","current":-18.24359,"twenty":-13.053431,"median":-3.807696,"eighty":-1.785226,"marketCap":175247927},{"date":"2025-02-07","current":-20.619856,"twenty":-13.179071,"median":-3.887749,"eighty":-1.785226,"marketCap":198074338},{"date":"2025-02-14","current":-20.389895,"twenty":-13.360254,"median":-4.058015,"eighty":-1.785226,"marketCap":195865330},{"date":"2025-02-21","current":-18.626859,"twenty":-13.491058,"median":-4.162726,"eighty":-1.785226,"marketCap":178929606},{"date":"2025-02-28","current":-17.860321,"twenty":-13.571831,"median":-4.258509,"eighty":-1.785226,"marketCap":171566248},{"date":"2025-03-07","current":-18.166936,"twenty":-13.797673,"median":-4.37017,"eighty":-1.781917,"marketCap":174511591},{"date":"2025-03-14","current":-16.633862,"twenty":-14.027634,"median":-4.426926,"eighty":-1.806013,"marketCap":159784875},{"date":"2025-03-21","current":62.809311,"twenty":-14.199078,"median":-4.426926,"eighty":-1.781917,"marketCap":184156900},{"date":"2025-03-28","current":68.664416,"twenty":-14.199078,"median":-4.426926,"eighty":-1.731486,"marketCap":201324069},{"date":"2025-04-04","current":69.196699,"twenty":-14.199078,"median":-4.426926,"eighty":9.414507,"marketCap":202884721},{"date":"2025-04-11","current":61.478605,"twenty":-14.164789,"median":-4.426926,"eighty":9.60692,"marketCap":180255271},{"date":"2025-04-17","current":69.196699,"twenty":-14.164789,"median":-4.37017,"eighty":9.758102,"marketCap":202884721},{"date":"2025-04-25","current":78.245498,"twenty":-14.199078,"median":-4.058015,"eighty":9.826821,"marketCap":229415799},{"date":"2025-05-02","current":79.842345,"twenty":-14.199078,"median":-3.731273,"eighty":9.895541,"marketCap":234097755},{"date":"2025-05-09","current":76.914792,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"marketCap":225514170},{"date":"2025-05-16","current":34.018394,"twenty":-14.199078,"median":-3.44594,"eighty":10.055382,"marketCap":132943882},{"date":"2025-05-23","current":33.610987,"twenty":-14.199078,"median":-3.37695,"eighty":10.101698,"marketCap":131351739},{"date":"2025-05-30","current":32.38877,"twenty":-14.199078,"median":-3.34545,"eighty":10.107067,"marketCap":126575312},{"date":"2025-06-06","current":30.962849,"twenty":-14.199078,"median":-3.320194,"eighty":10.170417,"marketCap":121002814},{"date":"2025-06-13","current":31.370255,"twenty":-14.199078,"median":-3.291817,"eighty":10.239136,"marketCap":122594957},{"date":"2025-06-20","current":28.518414,"twenty":-14.027634,"median":-3.241732,"eighty":10.37073,"marketCap":111449961},{"date":"2025-06-27","current":29.536928,"twenty":-13.848978,"median":-3.190184,"eighty":10.376574,"marketCap":115430316},{"date":"2025-07-03","current":31.370255,"twenty":-13.848978,"median":-3.149439,"eighty":10.459037,"marketCap":122594957},{"date":"2025-07-11","current":30.148037,"twenty":-13.848978,"median":-3.108336,"eighty":10.583107,"marketCap":117818530},{"date":"2025-07-18","current":30.555443,"twenty":-13.848978,"median":-3.054751,"eighty":10.65145,"marketCap":119410672},{"date":"2025-07-25","current":31.573958,"twenty":-13.848978,"median":-3.021648,"eighty":10.720591,"marketCap":123391028},{"date":"2025-08-01","current":29.740631,"twenty":-13.848978,"median":-3.006967,"eighty":10.793764,"marketCap":116226387},{"date":"2025-08-08","current":30.759146,"twenty":-13.848978,"median":-2.971366,"eighty":10.903709,"marketCap":120206743},{"date":"2025-08-15","current":19.313596,"twenty":-13.644366,"median":-2.937379,"eighty":11.065777,"marketCap":121192814},{"date":"2025-08-22","current":20.075975,"twenty":-13.429736,"median":-2.919172,"eighty":11.134452,"marketCap":125976741},{"date":"2025-08-29","current":19.694785,"twenty":-13.123121,"median":-2.8825,"eighty":11.169615,"marketCap":123584778},{"date":"2025-09-05","current":20.203038,"twenty":-12.90849,"median":-2.875275,"eighty":11.241514,"marketCap":126774062},{"date":"2025-09-12","current":22.108985,"twenty":-12.628566,"median":-2.846166,"eighty":11.42538,"marketCap":138733880},{"date":"2025-09-19","current":23.633742,"twenty":-12.250828,"median":-2.825981,"eighty":11.601155,"marketCap":148301733},{"date":"2025-09-26","current":25.920879,"twenty":-10.604625,"median":-2.799067,"eighty":11.743105,"marketCap":162653514},{"date":"2025-10-03","current":29.732773,"twenty":-10.114998,"median":-2.793273,"eighty":11.832516,"marketCap":186573149},{"date":"2025-10-10","current":32.528162,"twenty":-9.805062,"median":-2.772152,"eighty":11.957111,"marketCap":204114214},{"date":"2025-10-17","current":30.495152,"twenty":-9.762245,"median":-2.772018,"eighty":11.990948,"marketCap":191357076},{"date":"2025-10-24","current":29.351583,"twenty":-9.666843,"median":-2.745238,"eighty":12.062818,"marketCap":184181185},{"date":"2025-10-31","current":28.716268,"twenty":-9.575656,"median":-2.745238,"eighty":12.09801,"marketCap":180194579},{"date":"2025-11-07","current":28.208015,"twenty":-9.495624,"median":-2.743583,"eighty":12.205072,"marketCap":177005295},{"date":"2025-11-14","current":24.73512,"twenty":-9.387308,"median":-2.699686,"eighty":12.300707,"marketCap":155212879},{"date":"2025-11-21","current":25.942316,"twenty":-9.269689,"median":-2.615734,"eighty":12.37938,"marketCap":139932854},{"date":"2025-11-28","current":26.538692,"twenty":-9.163458,"median":-2.567994,"eighty":12.464912,"marketCap":143149702},{"date":"2025-12-05","current":26.09141,"twenty":-9.067701,"median":-2.545381,"eighty":12.526258,"marketCap":140737066},{"date":"2025-12-12","current":27.28416,"twenty":-8.948724,"median":-2.50209,"eighty":12.602031,"marketCap":147170761},{"date":"2025-12-19","current":26.836879,"twenty":-8.571936,"median":-2.480199,"eighty":12.656675,"marketCap":144758125},{"date":"2025-12-26","current":26.389598,"twenty":-8.326335,"median":-2.442358,"eighty":12.851357,"marketCap":142345490},{"date":"2026-01-02","current":26.836879,"twenty":-8.103377,"median":-2.417254,"eighty":13.056001,"marketCap":144758125},{"date":"2026-01-09","current":29.818755,"twenty":-7.958628,"median":-2.392428,"eighty":13.349518,"marketCap":160842362},{"date":"2026-01-16","current":30.713317,"twenty":-7.818489,"median":-2.365591,"eighty":13.606859,"marketCap":165667632},{"date":"2026-01-23","current":31.160598,"twenty":-7.77061,"median":-2.332944,"eighty":13.811003,"marketCap":168080268},{"date":"2026-01-30","current":30.862411,"twenty":-7.691977,"median":-2.280199,"eighty":14.105455,"marketCap":166471844},{"date":"2026-02-06","current":43.386288,"twenty":-7.664219,"median":-2.244114,"eighty":14.877476,"marketCap":234025636},{"date":"2026-02-13","current":42.640819,"twenty":-7.611331,"median":-2.19949,"eighty":15.295653,"marketCap":230004577},{"date":"2026-02-20","current":46.964538,"twenty":-7.442925,"median":-2.182913,"eighty":15.440407,"marketCap":253326720},{"date":"2026-02-27","current":44.877225,"twenty":-7.195944,"median":-2.160903,"eighty":15.617329,"marketCap":242067754},{"date":"2026-03-06","current":41.448069,"twenty":-7.108399,"median":-2.136786,"eighty":16.019423,"marketCap":223570883},{"date":"2026-03-13","current":41.597162,"twenty":-6.991466,"median":-2.122315,"eighty":19.466072,"marketCap":224375094},{"date":"2026-03-20","current":-27.20696,"twenty":-6.909674,"median":-2.122315,"eighty":19.694785,"marketCap":179674761}],"updateTime":1774234969362},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584925534","title":"Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925534?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:27","pubTimestamp":1763569669,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - CHIESI GLOBAL RARE DISEASES-:*CHIESI GLOBAL RARE DISEASES - REQUESTS RE-EXAMINATION OF NEGATIVE OPINION ISSUED BY EMA'S CHMP ON PROPOSED DOSING REGIMEN OF 2 MG/KG EVERY 4 WEEKS FOR E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1lLSpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2584776999","title":"Bernstein Remains a Hold on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584776999","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584776999?lang=en_us&edition=fundamental","pubTime":"2025-11-19 11:16","pubTimestamp":1763522162,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sabrina Blanc from Bernstein maintained a Hold rating on PLUXEE N.V.. The company’s shares closed last Monday at €1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2584930939","title":"Kepler Capital  Remains a Buy on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584930939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584930939?lang=en_us&edition=fundamental","pubTime":"2025-11-19 09:46","pubTimestamp":1763516767,"startTime":"0","endTime":"0","summary":"In a report released on November 17, Julien Richer from Kepler Capital maintained a Buy rating on PLUXEE N.V., with a price target of €28.00. The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2584876479","title":"Protalix BioTherapeutics showcases pipeline advances and growth strategy for rare disease treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2584876479","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584876479?lang=en_us&edition=fundamental","pubTime":"2025-11-18 16:56","pubTimestamp":1763456200,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has provided an update on its clinical and commercial pipeline. The company reported $53 million in revenue for the full year 2024 and $25.4 million in revenue from selling goods during the first half of 2025. As of June 30, 2025, Protalix holds $33.4 million in cash, with no debt or outstanding warrants, and anticipates becoming cash flow positive in the first half of 2027. The company's commercial portfolio includes approved enzyme replacement therapies for Fabry disease and Gaucher disease, with market presence in the US, EU, and additional regions. In its development pipeline, Protalix highlights PRX-115, a recombinant PEGylated uricase candidate for uncontrolled gout, with Phase 2 studies expected to begin in the fourth quarter of 2025. The company also reports ongoing research in rare renal diseases and other NETs-related diseases. Key upcoming milestones include expanding market share for existing products, pursuing additional geographic approvals, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL8VvndK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2584840579","title":"Barclays Keeps Their Hold Rating on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584840579","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584840579?lang=en_us&edition=fundamental","pubTime":"2025-11-18 16:16","pubTimestamp":1763453779,"startTime":"0","endTime":"0","summary":"Barclays analyst Pravin Gondhale maintained a Hold rating on PLUXEE N.V. today and set a price target of €20.00. According to TipRanks, Gondhale is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-pluxee-n-v-plx-blurbs-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-pluxee-n-v-plx-blurbs-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2583254938","title":"Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2583254938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583254938?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:37","pubTimestamp":1763080660,"startTime":"0","endTime":"0","summary":"Protalix Biotherapeutics (($PLX)) has held its Q3 earnings call. Read on for the main highlights of the call. Protalix BioTherapeutics’ recent earn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-highlights-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2583636562","title":"Protalix BioTherapeutics Q3 EPS USD 0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2583636562","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583636562?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:04","pubTimestamp":1763035494,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Protalix BioTherapeutics Q3 pretax profit USD 2.239 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202511:00:00.18 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nRSD6SWMs1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2583564535","title":"Protalix BioTherapeutics Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.673M Miss $17.866M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583564535","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583564535?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:51","pubTimestamp":1763034676,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.06 by 45.45 percent. This is unchanged from the same period last year.  The company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48829545/protalix-biotherapeutics-q3-eps-0-03-misses-0-06-estimate-sales-17-673m-miss-17-866m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2583566564","title":"Press Release: Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583566564","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583566564?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:50","pubTimestamp":1763034600,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:00 a.m. EST. CARMIEL, Israel, Nov. 13, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today reported financial results for the quarter ended September 30, 2025, and provided a financial and business update.\"We are pleased to report total revenues of $43.6 million for the first nine months of 2025, an increase of 24%, compared to the same period in 2024. Our total revenues for the third quarter were $17.9 million which reflects a decrease of 1%, compared to revenues for the same period of 2024,\" said Dror Bashan, Protalix's President and Chief Executive Officer. \"We recognize revenues from sales of our products to Chiesi, Pfizer, and Fiocruz in Brazil, and their purchases vary from quarter to quarter as they control their ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","LU1066053197.SGD","LU1066051498.USD","BK4585","SG9999011175.SGD","LU0985481810.HKD","LU1023059063.AUD","IE00B19Z3581.USD","LU0456855351.SGD","LU0868494617.USD","BK4007","LU1894683348.USD","LU1894683264.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0306807586.USD","LU0170899867.USD","SG9999002232.USD","BK4581","LU0289739699.SGD","SG9999002224.SGD","LU0225284248.USD","SG9999001176.SGD","PLX","IE00B19Z3B42.SGD","SGXZ57979304.SGD","EMA","LU0122379950.USD","LU1057294990.SGD","BK4022","BK4592","BK4599","BK4568","BK4139","LU0225771236.USD","LU0234572021.USD","LU1883839398.USD","LU0321505868.SGD","BK4081","IE00BBT3K403.USD","LU0321505439.SGD","R","LU0306806265.USD","SG9999001176.USD","BK4534","SG9999013999.USD","LU0058720904.USD","BK4533","CHMP"],"gpt_icon":1},{"id":"2581064332","title":"Protalix BioTherapeutics Inc. to Report Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064332","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064332?lang=en_us&edition=fundamental","pubTime":"2025-11-06 19:50","pubTimestamp":1762429816,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via PR Newswire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDLbd13VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2581511647","title":"Bernstein Reaffirms Their Hold Rating on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581511647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581511647?lang=en_us&edition=fundamental","pubTime":"2025-11-05 00:35","pubTimestamp":1762274146,"startTime":"0","endTime":"0","summary":"Bernstein analyst Sabrina Blanc maintained a Hold rating on PLUXEE N.V. today and set a price target of €17.70. The company’s shares closed yesterd...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-hold-rating-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-hold-rating-on-pluxee-n-v-plx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2580278512","title":"Chiesi Global Rare Diseases Seeks Ema Chmp Re-Exam Of Negative View On Elfabrio 2 Mg/Kg Q4w Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580278512","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580278512?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:46","pubTimestamp":1762213595,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - CHIESI GLOBAL RARE DISEASES-:*CHIESI GLOBAL RARE DISEASES - REQUESTS RE-EXAMINATION OF NEGATIVE OPINION ISSUED BY EMA'S CHMP ON PROPOSED DOSING REGIMEN OF 2 MG/KG EVERY 4 WEEKS FOR E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nRSD1lLSpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2580263762","title":"Protalix BioTherapeutics and Chiesi Seek EMA Re-examination for Elfabrio Alternative Dosing in EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2580263762","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580263762?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:44","pubTimestamp":1762206291,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. and Chiesi Global Rare Diseases have requested a re-examination from the European Medicines Agency  after receiving a negative opinion from the Committee for Medicinal Products for Human Use  regarding the proposed alternative dosing regimen of Elfabrio  at 2 mg/kg every four weeks. The currently approved dosing regimen of 1 mg/kg every two weeks remains in effect while the re-examination process is ongoing. The companies remain committed to working with the EMA to address the needs of the Fabry disease community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protalix BioTherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL8ZTT7d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2580779429","title":"J.P. Morgan Sticks to Its Hold Rating for PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580779429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580779429?lang=en_us&edition=fundamental","pubTime":"2025-11-01 20:07","pubTimestamp":1761998822,"startTime":"0","endTime":"0","summary":"In a report released on October 30, Estelle Weingrod from J.P. Morgan maintained a Hold rating on PLUXEE N.V., with a price target of €23.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-hold-rating-for-pluxee-n-v-plx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-hold-rating-for-pluxee-n-v-plx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2580465844","title":"PLUXEE N.V. (PLX) Gets a Buy from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2580465844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580465844?lang=en_us&edition=fundamental","pubTime":"2025-11-01 09:49","pubTimestamp":1761961772,"startTime":"0","endTime":"0","summary":"In a report released on October 30, Julien Richer from Kepler Capital maintained a Buy rating on PLUXEE N.V., with a price target of €30.00. The co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-buy-from-kepler-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-buy-from-kepler-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2579145049","title":"PLUXEE N.V. (PLX) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2579145049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579145049?lang=en_us&edition=fundamental","pubTime":"2025-10-31 18:38","pubTimestamp":1761907083,"startTime":"0","endTime":"0","summary":"UBS analyst Justin Forsythe maintained a Hold rating on PLUXEE N.V. today and set a price target of €19.00. The company’s shares closed yesterday a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-hold-from-ubs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-hold-from-ubs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UBS","BK4588","BK4534","BK4139","LU1829250122.USD","BK4585","IE0034235071.USD","PLX","BK4118"],"gpt_icon":0},{"id":"2577866044","title":"How Could EMA's Elfabrio Decision Reshape Protalix BioTherapeutics' (PLX) Rare Disease Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2577866044","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577866044?lang=en_us&edition=fundamental","pubTime":"2025-10-20 21:16","pubTimestamp":1760966206,"startTime":"0","endTime":"0","summary":"Earlier in October 2025, Protalix BioTherapeutics and Chiesi Group received a negative opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) regarding Elfabrio’s proposed less-frequent dosing regimen for Fabry disease, as the data was considered insufficient to demonstrate similar efficacy to the currently approved schedule.\nThis regulatory decision highlights ongoing challenges in achieving flexibility for rare disease treatments, with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nysemkt-plx/protalix-biotherapeutics/news/how-could-emas-elfabrio-decision-reshape-protalix-biotherape","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nysemkt-plx/protalix-biotherapeutics/news/how-could-emas-elfabrio-decision-reshape-protalix-biotherape","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CHMP","EMA","BK4081","BK4087","PLX","BK4139"],"gpt_icon":0},{"id":"2576505793","title":"Why Is Protalix BioTherapeutics Stock Falling On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576505793","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576505793?lang=en_us&edition=fundamental","pubTime":"2025-10-17 23:23","pubTimestamp":1760714580,"startTime":"0","endTime":"0","summary":"EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/17/Medicine-And-Health-Concept--On-A-White-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/17/Medicine-And-Health-Concept--On-A-White-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/10/48278076/why-is-protalix-biotherapeutics-stock-falling-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/10/48278076/why-is-protalix-biotherapeutics-stock-falling-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["EMA","BK4087","CHMP","LU0320765992.SGD","LU0889565916.HKD","BK4081","PLX","BK4139","QURE","LU0109394709.USD"],"gpt_icon":0},{"id":"2576105304","title":"Protalix Shares Sink After EMA Rejects Once-Monthly Treatment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2576105304","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576105304?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:28","pubTimestamp":1760707680,"startTime":"0","endTime":"0","summary":"Shares of Protalix BioTherapeutics fell after the company said the European Medicines Agency rejected its request to approve a once-every-four-weeks dosing schedule for its Fabry disease treatment, Elfabrio.The stock tumbled 30% to $1.67 in premarket trading Friday. Through Thursday's close, shares are up 28% so far this year.The Israel-based company, which developed Elfabrio alongside Chiesi Global Rare Diseases, part of Italy-based Chiesi Group, had been seeking approval for a new, less frequent dosing regimen for Elfabrio. The treatment is currently approved at a lower dose, once every two weeks.Protalix and Chiesi submitted data from a recent study testing the monthly dosing in patients who had already been using the drug. However, the agency's Committee for Medicinal Products for Human Use concluded that data wasn't strong enough to prove it had the same efficacy as that of the currently approved schedule, the companies said on Friday.\"We are disappointed by the result of this rev","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK4081","PLX","BK4139"],"gpt_icon":0},{"id":"2576375270","title":"Protalix BioTherapeutics Highlights Rare Disease Drug Pipeline and New Gout Therapy in Latest Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2576375270","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576375270?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:09","pubTimestamp":1760702997,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics Inc. has released a corporate presentation detailing its current pipeline and financial status. The company reported $53 million in revenue for the full year 2024 and $25.4 million in revenue from product sales in the first half of 2025. As of June 30, 2025, Protalix holds $33.4 million in cash with no debt or warrants, supporting its operations and pipeline development into 2027. Protalix highlighted its commercial portfolio, which includes approved enzyme replacement therapies for Fabry disease and Gaucher disease in the United States, European Union, and additional markets. The development portfolio features PRX-115, a PEGylated uricase candidate targeting uncontrolled gout, with a Phase 2 trial expected to begin in the fourth quarter of 2025. The company is also advancing PRX-119, a long-acting DNase I, and is pursuing additional programs in rare renal and NETs-related diseases. Over the next three years, Protalix aims to expand its pipeline to five to seve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL1vNnGB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}